According to Karuna Therapeutics's latest financial reports the company's current EPS (TTM) is -$10.15. In 2022 the company made an earnings per share (EPS) of -$8.72 a decrease over its 2021 EPS that were of -$4.93.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$10.15 | 16.4% |
2022 | -$8.72 | 76.88% |
2021 | -$4.93 | 91.09% |
2020 | -$2.58 | -98.25% |
2019 | -$147.29 | 9038.75% |
2018 | -$1.61 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | -$2.18 | -78.52% | ๐บ๐ธ USA |